Gotowa bibliografia na temat „Marine drugs”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Marine drugs”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Marine drugs"
Lu, Xiao-Ling, Qiang-Zhi Xu, Xiao-Yu Liu, Xin Cao, Kun-Yi Ni i Bing-Hua Jiao. "Marine Drugs - Macrolactins". Chemistry & Biodiversity 5, nr 9 (24.09.2008): 1669–74. http://dx.doi.org/10.1002/cbdv.200890155.
Pełny tekst źródłaGallo, Carmela, i Genoveffa Nuzzo. "Drugs from Marine Sources". Applied Sciences 11, nr 24 (20.12.2021): 12115. http://dx.doi.org/10.3390/app112412115.
Pełny tekst źródłaGuan, Hua-Shi. "The Journal Marine Drugs and the First International Symposium on Marine Drugs (2004)". Marine Drugs 1, nr 1 (15.11.2003): 3–4. http://dx.doi.org/10.3390/md101003.
Pełny tekst źródłaFarooqi, Ammad, Sundas Fayyaz, Ming-Feng Hou, Kun-Tzu Li, Jen-Yang Tang i Hsueh-Wei Chang. "Reactive Oxygen Species and Autophagy Modulation in Non-Marine Drugs and Marine Drugs". Marine Drugs 12, nr 11 (13.11.2014): 5408–24. http://dx.doi.org/10.3390/md12115408.
Pełny tekst źródłaJaved, Faraza, M. Imran Qadir, Khalid Hussain Janbaz i Muhammad Ali. "Novel drugs from marine microorganisms". Critical Reviews in Microbiology 37, nr 3 (20.05.2011): 245–49. http://dx.doi.org/10.3109/1040841x.2011.576234.
Pełny tekst źródłaShikov, Alexander N., Elena V. Flisyuk, Ekaterina D. Obluchinskaya i Olga N. Pozharitskaya. "Pharmacokinetics of Marine-Derived Drugs". Marine Drugs 18, nr 11 (9.11.2020): 557. http://dx.doi.org/10.3390/md18110557.
Pełny tekst źródłaBelarbi, E. "Producing drugs from marine sponges". Biotechnology Advances 21, nr 7 (październik 2003): 585–98. http://dx.doi.org/10.1016/s0734-9750(03)00100-9.
Pełny tekst źródłaGrosso, Clara, Patrícia Valentão, Federico Ferreres i Paula Andrade. "Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases". Marine Drugs 12, nr 5 (2.05.2014): 2539–89. http://dx.doi.org/10.3390/md12052539.
Pełny tekst źródłaRusso, Patrizia, i Alfredo Cesario. "New Anticancer Drugs from Marine Cyanobacteria". Current Drug Targets 13, nr 8 (1.06.2012): 1048–53. http://dx.doi.org/10.2174/138945012802009035.
Pełny tekst źródłaDe, Oindrila, i Biswa P. Chatterji. "Marine Derived Anticancer Drugs Targeting Microtubule". Recent Patents on Anti-Cancer Drug Discovery 12, nr 2 (5.06.2017): 102–27. http://dx.doi.org/10.2174/1574892812666170109141003.
Pełny tekst źródłaRozprawy doktorskie na temat "Marine drugs"
Bannerman-Akwei, Laude. "Synthesis of Marine Chemicals and Derivatives as Potential Anti-Cancer Drugs". Digital Commons @ East Tennessee State University, 2008. https://dc.etsu.edu/etd/1990.
Pełny tekst źródłaLane, Amy L. "Marine natural products as antimicrobial chemical defenses and sources of potential drugs". Diss., Atlanta, Ga. : Georgia Institute of Technology, 2008. http://hdl.handle.net/1853/26556.
Pełny tekst źródłaCommittee Chair: Kubanek, Julia; Committee Member: Fernandez, Facundo M.; Committee Member: Harvey, Stephen C.; Committee Member: Hay, Mark E.; Committee Member: Hud, Nicholas V. Part of the SMARTech Electronic Thesis and Dissertation Collection.
Sunkel, Vanessa Ann. "The investigation of novel marine microorganisms for the production of biologically active metabolites". Thesis, Rhodes University, 2009. http://hdl.handle.net/10962/d1004579.
Pełny tekst źródłaKMBT_363
Adobe Acrobat 9.54 Paper Capture Plug-in
Watson, Daniel John. "Studies directed towards the total asymmetric synthesis of Altohyrtin A". Thesis, University of Liverpool, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.364263.
Pełny tekst źródłaLlorach, Parés Laura. "Computer-Aided Drug Design applied to marine drug discovery = Disseny de fàrmacs assistit per ordinador aplicat a la cerca de possibles fàrmacs marins". Doctoral thesis, Universitat de Barcelona, 2019. http://hdl.handle.net/10803/668298.
Pełny tekst źródłaEl potencial dels productes naturals en general, i els productes naturals marins en particular, com a entitats farmacològiques ha quedat demostrat al llarg dels últims anys. Els ecosistemes bentònics marins contenen una extraordinària diversitat d'organismes que posseeixen compostos naturals bioactius, que utilitzen com mecanismes químics defensius i de protecció. Aquestes efectives estratègies defensives es basen en metabòlits secundaris, crucials per a la supervivència de les espècies. Tenint en compte les propietats farmacològiques d'aquests compostos químics únics, utilitzar-los per al desenvolupament de nous fàrmacs constitueix una línia interessant de recerca emergent. L'evolució, la biodiversitat i les condicions específiques que es troben en els ecosistemes marins, com ara l'Antàrtida i el mar Mediterrani, els converteixen en una font increïble de possibles agents terapèutics, capaços de modular funcions de proteïnes involucrades en determinades patologies. El procés de descobriment i desenvolupament de nous fàrmacs, per exemple, molècules petites, és un procediment tediós que requereix de recursos econòmics i de temps. Per reduir aquests inconvenients, el disseny de fàrmacs assistit per ordinador (DFAO) ha sorgit com un dels mètodes principals i més eficaços. Es pot fer una exploració ràpida de l'espai químic amb mètodes computacionals i a més, són aproximacions complementàries als mètodes experimentals molt interessants i útils. Les tècniques de DFAO es poden aplicar en diferents passos del procés de descobriment de fàrmacs, i també, poden cobrir diverses fases d'aquest pipeline. Amb aquesta finalitat, es varen establir diversos objectius en aquesta tesi: 1. Dilucidar la possible activitat terapèutica i la capacitat per modular les funcions de proteïnes que estan relacionades amb una determinada patologia de les molècules marines mitjançant l'ús de diferents eines i tècniques de DFAO: I. millorar el pipeline de descobriment de fàrmacs mitjançant l'elucidació del possible potencial terapèutic d'un conjunt de molècules marines enfront d'una llista de dianes relacionades amb diferents patologies. II. Dilucidació de les diferents característiques farmacofóriques dels compostos marins i en un precís estudi d’unió in silico, destacant el poder de les tècniques de DFAO, i avaluar l'activitat inhibidora de diferents productes naturals i derivats d’esquelets indòlics com inhibidors de GSK3β, CK1δ, DYRK1A i CLK1. III. Estudi computacional i validació experimental de meridianines i lignarenones com a possibles inhibidors de GSK3β mitjançant la unió a la cavitat de l'ATP i/o del substrat. En relació amb aquests objectius, les conclusions principals d'aquesta tesi són, que les molècules marines poden ser utilitzades com a agents terapèutics contra proteïnes quinases relacionades amb la malaltia d’Alzheimer, i l'exemplificació del potencial de les tècniques de DFAO aplicat al descobriment de fàrmacs marins.
Mezzelani, Marica. "Ecotoxicological potential of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in marine organisms: bioavailability, biomarkers and natural occurrence in Mytilus galloprovincialis". Doctoral thesis, Università Politecnica delle Marche, 2016. http://hdl.handle.net/11566/243116.
Pełny tekst źródłaPharmaceuticals represent a major environmental concern since the knowledge on their occurrence, distribution and ecotoxicological potential is still limited particularly in coastal areas. In this thesis the sensitivity of the Mediterranean mussels Mytilus galloprovincialis toward different Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) was assessed, applying an integrated approach which combined laboratory studies with field investigation. In laboratory conditions mussels were exposed to different environmental realistic concentrations (25, 2.5 and 0.5 μg/L) of acetaminophen AMP, diclofenac DIC, ibuprofen IBU, ketoprofen KET and nimesulide NIM, for different periods (from 14 to 60 days). The ecotoxicological potential of NSAIDs was evaluated combining chemical analyses on pharmaceuticals bioaccumulation with a multi-biomarker approach, based on a wide array of molecular and subcellular responses reflecting early warning signals of biological disturbance, modulation of specific cellular pathways, onset of various typologies of cellular damages and toxicity. For some experimental condition, functional alteration at cellular level were further integrated with transcriptomic changes at molecular level using DNA microarray. Obtained results demonstrated that mussels are able to bioconcentrate DIC, IBU and NIM without dose dependent response, while AMP and KET are never detected independently from the doses and the exposure period. Nonetheless, for all tested NSAIDs and in all experimental conditions, measurement of a large panel of ecotoxicological biomarkers highlighted impairment of immunological parameters, modulation of lipid metabolism and genotoxic effects. The analyses on transcriptomic profile highlighted changes at molecular level for organisms exposed to lower doses, both in short (for KET and NIM) and long-term condition (for KET). Molecular results supported changes obtained at cellular level and suggest similar mechanisms of action of NSAIDs in mammals and vertebrates. Long-term responses allowed to determine that the effects of anti-inflammatory pharmaceuticals were constantly maintained over 60 days. Field studies provided the first evidence on the occurrence of DIC, IBU and NIM in tissues of wild mussels sampled during summer and spring periods from typical, touristic areas of Central Adriatic Sea. Overall results demonstrated M. galloprovincialis as a good sentinel species toward anti inflammatory pharmaceuticals and the actual ecotoxicological hazard of pharmaceuticals in the Mediterranean.
Noor, Humaira. "Immunological Effects of Haliotis Rubra Hemolymph and Hemolymph Components". Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/17063.
Pełny tekst źródłaBovio, Elena. "Champignons marins d'éponges marines : biodiversité, chimiodiversité et applications biotechnologiques". Thesis, Université Côte d'Azur (ComUE), 2019. http://theses.univ-cotedazur.fr/2019AZUR4009.
Pełny tekst źródłaMarine environment represents an untapped source of fungal diversity, where it has been estimated that about 10% of fungi have been explored until now. Due to the lack of knowledge on marine fungi and their incredible biotechnological potential, this Ph.D. thesis focuses on a highly promising group of fungi: those associated with marine sponges. These fungi are both characterized by high biodiversity and chemodiversity, being the most successful producers of new bioactive molecules. On these premises, the main goal of the research was to cover the firsts and fundamentals aspects of the natural products discovery pipeline: from the isolation and identification of fungi from sponges to the isolation of molecules and the evaluation of their biological activity. This resulted in a multidisciplinary Ph.D. project that enclosed mycology, chemistry, biochemistry and biotechnology. In a “funnel-like” perspective, using multidisciplinary experimental approaches three main parts were developed: - The first aim was to isolate the fungal communities associated with sponges using several isolation techniques to increase the number of cultivable fungi. Four and three sponges were respectively collected in the Atlantic Ocean and in the Mediterranean Sea. Overall, 129 taxa were obtained; thanks to a polyphasic approach based on morphological, molecular and phylogenetic techniques, 84.5% of them were identified at the species level. Two fungal species Thelebolus balaustiformis and Thelebolus spongiae were here first described, updating the knowledge on marine fungal diversity. This work underlined the specificity of the fungal community for each sponge, leading to think that these animals are able to recruit their own mycobiota. - The second part was based on the investigation of the chemical diversity of marine fungi associated with the sponge Grantia compressa, using the OSMAC approach (One Strain – Many Compounds). Not surprisingly, it has been difficult to define a condition that promotes both the development of the mycelium and the secondary metabolites production for all fungi; generally, rich nutrients media are the best candidates to achieve the above-mentioned results. Among the tested fungi, Eurotium chevalieri MUT 2316 produce more metabolites than any other fungus and ten pure compounds were isolated. - The third part of this Ph.D. project aimed to test the biological activity of the ten fungal molecules. Two main research fields, pharmaceutical and environmental, were chosen as potential targets. Six compounds showed antibacterial activity, with isodihydroauroglaucin active against most of the Grampositive bacteria tested also with bactericidal activity. Dihydroauroglaucin and physcion were able to completely inhibit the replication of Influenza A virus, while neoechinulin completely inhibited Herpes Simplex Virus 1. Finally, the last series of bioassays aimed to face the urgent need of environmentally friendly antifouling and highlighted several molecules already active at extremely low concentrations, inhibiting the adhesion and growth of both bacteria and microalgae. As result, a mix of few compounds produced by E. chevalieri MUT 2316 would inhibit all the bacteria and microalgae tested. In conclusion, this Ph.D. project highlighted the outstanding biodiversity and chemodiveristy of marine fungi inhabiting sponges. The molecules isolated from E. chevalieri MUT 2316 found applications in different research fields and represent promising candidates for the development of new drugs and antifouling paints
Hagos, Selam. "Chemical Investigation of Bioactive Marine Extracts". Scholar Commons, 2018. https://scholarcommons.usf.edu/etd/7301.
Pełny tekst źródłaHoussen, Wael E. "Chemical, biological and molecular approaches toward drug discovery from marine organisms". Thesis, University of Aberdeen, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.439971.
Pełny tekst źródłaKsiążki na temat "Marine drugs"
Kim, Se-Kwon, red. Handbook of Anticancer Drugs from Marine Origin. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-07145-9.
Pełny tekst źródłaAnti-inflammatory drugs from plant and marine sources. Basel: Birkhauser, 1989.
Znajdź pełny tekst źródłaShah, Muhammad Dawood, Julian Ransangan i Balu Alagar Venmathi Maran, red. Marine Biotechnology: Applications in Food, Drugs and Energy. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-0624-6.
Pełny tekst źródła1948-, Dierauf Leslie A., red. CRC handbook of marine mammal medicine: Health, disease, and rehabilitation. Boca Raton, Fla: CRC Press, 1990.
Znajdź pełny tekst źródłaSex, drugs, and sea slime: The oceans' oddest creatures and why they matter. Chicago: University of Chicago Press, 2011.
Znajdź pełny tekst źródłaUnited States. Congress. House. Committee on Merchant Marine and Fisheries. Subcommittee on Coast Guard and Navigation. Airborne Drug Trafficking Deterrence Act: Hearing before the Subcommittee on Coast Guard and Navigation of the Committee on Merchant Marine and Fisheries, House of Representatives, One Hundred First Congress, second session, on H.R. 1343 ... H.R. 5301 ... October 2, 1990. Washington: U.S. G.P.O., 1991.
Znajdź pełny tekst źródłaUnited States. National Transportation Safety Board. Postaccident testing for alcohol and other drugs in the marine industry and the ramming of the Portland-South Portland (million dollar) Bridge at Portland, Maine, by the Liberian tankship Julie N on September 27, 1996. Washington, D.C. (490 L'Enfant Palza, S.W. Washington 20594): The Board, 1998.
Znajdź pełny tekst źródłaUnited States. Congress. House. Committee on Merchant Marine and Fisheries. Subcommittee on Coast Guard and Navigation. Coast Guard drug activities: Hearing before the Subcommittee on Coast Guard and Navigation of the Committee on Merchant Marine and Fisheries, House of Representatives, One Hundredth Congress, second session, on H.R. 4230, H.R. 4446, H.R. 4608, and 4658, bills to enforce drug laws, to curtail the flow of drugs into the United States, and promote a "drug free" America, June 15, 1988. Washington: U.S. G.P.O., 1988.
Znajdź pełny tekst źródłaUnited States. National Transportation Safety Board. Postaccident testing for alcohol and other drugs in the marine industry and the ramming of the Portland-South Portland (Million Dollar) Bridge at Portland, Maine, by the Liberian tankship Julie N on September 27, 1996: Special investigation report. Washington, D.C: National Transportation Safety Board, 1998.
Znajdź pełny tekst źródłaRossoff, Irving S. Encyclopedia of clinical toxicology: A comprehensive guide and reference to the toxicology of prescription and OTC drugs, chemicals, herbals, plants, fungi, marine life, reptiles and insect venoms, food ingredients, clothing, and environmental toxins. Boca Raton: Parthenon Pub. Group, 2002.
Znajdź pełny tekst źródłaCzęści książek na temat "Marine drugs"
Horta, André, Celso Alves, Susete Pinteus i Rui Pedrosa. "The marine origin of drugs". W Phycotoxins, 293–316. Chichester, UK: John Wiley & Sons, Ltd, 2015. http://dx.doi.org/10.1002/9781118500354.ch13.
Pełny tekst źródłaGomathi, T., Jayachandran Venkatesan i Sukumaran Anil. "Marine Biopolymers for Anticancer Drugs". W Industrial Applications of Marine Biopolymers, redaktor P. N. Sudha, 289–304. Boca Raton : CRC Press, [2017]: CRC Press, 2017. http://dx.doi.org/10.4324/9781315313535-11.
Pełny tekst źródłaGomathi, T., Jayachandran Venkatesan i Sukumaran Anil. "Marine Biopolymers for Anticancer Drugs". W Industrial Applications of Marine Biopolymers, redaktor P. Sudha, 289–304. Taylor & Francis Group, 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742: CRC Press, 2017. http://dx.doi.org/10.1201/9781315313535-15.
Pełny tekst źródłaSaeidnia, Soodabeh. "Marine-Derived Anticancer Compounds". W New Approaches to Natural Anticancer Drugs, 33–50. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-14027-8_3.
Pełny tekst źródłaJames, R. Arthur, S. Vignesh i K. Muthukumar. "Marine Drugs Development and Social Implication". W Coastal Environments: Focus on Asian Regions, 219–37. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-90-481-3002-3_15.
Pełny tekst źródłaKobayashi, M. "Search for Biologically Active Substances from Marine Sponges". W Drugs from the Sea, 46–58. Basel: KARGER, 2000. http://dx.doi.org/10.1159/000062481.
Pełny tekst źródłaQuesada, Ana R., Beatriz Martínez-Poveda, Salvador Rodríguez-Nieto i Miguel Ángel Medina. "Marine Sponge Derived Antiangiogenic Compounds". W Handbook of Anticancer Drugs from Marine Origin, 29–58. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07145-9_3.
Pełny tekst źródłaVansteelandt, Marieke, Catherine Roullier, Elodie Blanchet, Yann Guitton, Yves-François Pouchus, Nicolas Ruiz i Olivier Grovel. "Impact of Marine-DerivedPenicilliumSpecies in the Discovery of New Potential Antitumor Drugs". W Outstanding Marine Molecules, 45–84. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2014. http://dx.doi.org/10.1002/9783527681501.ch03.
Pełny tekst źródłaKim, Se-Kwon, i Senthilkumar Kalimuthu. "Introduction to Anticancer Drugs from Marine Origin". W Handbook of Anticancer Drugs from Marine Origin, 1–13. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07145-9_1.
Pełny tekst źródłaLi, Yong-Xin, i Se-Kwon Kim. "Triterpenoids as Anticancer Drugs from Marine Sponges". W Handbook of Anticancer Drugs from Marine Origin, 15–27. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07145-9_2.
Pełny tekst źródłaStreszczenia konferencji na temat "Marine drugs"
De La Calle, F. "Keynote Lecture “Marine Microbiome as Source of Innovative Drugs”". W GA – 70th Annual Meeting 2022. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1758907.
Pełny tekst źródłaAravindan, Sheeja, Somasundaram T. Somasundaram, Mohan Natarajan, Terence S. Herman i Natarajan Aravindan. "Abstract 2074: Bioactive marine drugs target acquired oncogenic burden in resilient pancreatic cancer". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-2074.
Pełny tekst źródłaAravindan, Sheeja, Somasundaram T. Somasundaram, Mohan Natarajan, Terence S. Herman i Natarajan Aravindan. "Abstract 2074: Bioactive marine drugs target acquired oncogenic burden in resilient pancreatic cancer". W Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-2074.
Pełny tekst źródłaWewengkang, Defny S., Henki Rotinsulu, Deiske A. Sumilat, Hiroyuki Yamazaki, Syu-Ichi Kanno i Michio Namikoshi. "Evaluation on bioactivity of ascidian collected in North Sulawesi as seeds of marine-derived drugs". W THE 2ND INTERNATIONAL CONFERENCE ON NATURAL SCIENCES, MATHEMATICS, APPLICATIONS, RESEARCH, AND TECHNOLOGY (ICON-SMART 2021): Materials Science and Bioinformatics for Medical, Food, and Marine Industries. AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0119405.
Pełny tekst źródłaPutri, Arlina Prima, Rizna Triana Dewi, Aniek Sri Handayani, Sri Harjanto i Mochamad Chalid. "Screening of proteins based on macro-algae from West Java coast in Indonesian marine as a potential anti-aging agent". W 2ND BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2017. Author(s), 2018. http://dx.doi.org/10.1063/1.5023966.
Pełny tekst źródłaViallet, Pierre M., Emmanuelle Rocchi, Jean Vigo i Jean-Marie Salmon. "Multiwavelength videomicrofluorimetric method for a preliminary, fast, and inexpensive screening of the cytoxic properties of new drugs: application to some new marine peptides". W BiOS '99 International Biomedical Optics Symposium, redaktorzy Tuan Vo-Dinh, Warren S. Grundfest, David A. Benaron, Steven T. Charles, Richard D. Bucholz i Michael W. Vannier. SPIE, 1999. http://dx.doi.org/10.1117/12.351540.
Pełny tekst źródłaTorres, Veronica C., Sassan Hodge, Rachael Chacko, Joshua J. Levy, Louis J. Vaickus, Eunice Y. Chen, Matthew LeBoeuf i Kimberley S. Samkoe. "Whole-tissue margin evaluation for Mohs surgery using paired-agent imaging". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/omp.2023.om3e.4.
Pełny tekst źródłaRounds, Cody C., Jaron de Wit, Jasper Vonk, Floris Voskuil, Max J. H. Witjes i Kenneth M. Tichauer. "Margin status assessment using a ratio-metric angular domain fluorescent imaging approach in patients with head and neck squamous cell carcinoma". W Optical Molecular Probes, Imaging and Drug Delivery. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/omp.2023.ow3e.3.
Pełny tekst źródłaMann, Charlotte. "12 Opioids in palliative care: initiating drug treatment". W Marie Curie Palliative Care Research Conference. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/spcare-2019-mariecuriepalliativecare.12.
Pełny tekst źródłaPenny, David. "A Fallen Line of Marble Drums". W Proceedings of EVA London 2022. BCS Learning & Development, 2022. http://dx.doi.org/10.14236/ewic/eva2022.52.
Pełny tekst źródłaRaporty organizacyjne na temat "Marine drugs"
Marchini, Geneviève Marthe Marie. Working paper PUEAA No. 16. The US exit from Afghanistan. Reverberation across Latin America. Universidad Nacional Autónoma de México, Programa Universitario de Estudios sobre Asia y África, 2023. http://dx.doi.org/10.22201/pueaa.001r.2023.
Pełny tekst źródła